Insider · CIK 0001127423
Robert J Deluccia
Files at ACXP (Acurx Pharmaceuticals, Inc.). First filing Jan 8, 2025, latest Jan 8, 2025.
In brief
Robert J Deluccia files SEC Form 4 as director and 10% owner at ACXP (Acurx Pharmaceuticals, Inc.). Since Jan 8, 2025, Robert J Deluccia has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Jan 8, 2025.
A track record needs three past buys with six months of prices behind them; Robert J Deluccia has 0, so none is measured yet.
The newest scored trade: bought $50k of ACXP on Jan 6, 2025, filed Jan 8, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACXP: Acurx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Acurx Pharmaceuticals, Inc. | $50k 49,261 shares | +5% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ACXP Acurx Pharmaceuticals, Inc. | AGrant or award Stock Optionderivative | +37,100 | $0.00 | $0 | 37,100 | Apr 22, 2026 |
| Feb 5, 2025 | ACXP Acurx Pharmaceuticals, Inc. | AGrant or award Stock Optionderivative | +250,000 | $0.00 | $0 | 250,000 | Feb 6, 2025 |
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +49,261 | $1.02 | $50k | 1,010,196 | Jan 8, 2025 |
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | POpen-market purchase Warrants for Common Stockderivative | +49,261 | $0.00 | $0 | 49,261 | Jan 8, 2025 |
| Dec 2, 2021 | ACXP Acurx Pharmaceuticals, Inc. | GGift Common Stock | -40,000 | $0.00 | $0 | 1,011,198 | Jan 4, 2024 |
| Dec 12, 2023 | ACXP Acurx Pharmaceuticals, Inc. | GGift Common Stock | -40,000 | $0.00 | $0 | 971,198 | Jan 4, 2024 |
| Dec 22, 2023 | ACXP Acurx Pharmaceuticals, Inc. | GGift Common Stock | -30,000 | $0.00 | $0 | 941,198 | Jan 4, 2024 |
| Jan 3, 2024 | ACXP Acurx Pharmaceuticals, Inc. | MOption exercise Common Stock | +19,737 | $3.55 | $70k | 960,935 | Jan 4, 2024 |
| Jan 3, 2024 | ACXP Acurx Pharmaceuticals, Inc. | MOption exercise Warrants for Common Stockderivative | -19,737 | $0.00 | $0 | 0 | Jan 4, 2024 |
Questions about Robert J Deluccia
Answered from the filings on this page, as of the latest one.
Is Robert J Deluccia buying or selling?
Not in the last 12 months. Robert J Deluccia's latest open-market trade on SEC Form 4 was bought $50k of ACXP on Jan 6, 2025.
How did Robert J Deluccia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert J Deluccia has 0.
Where does Robert J Deluccia file Form 4?
Robert J Deluccia has filed Form 4 at ACXP (Acurx Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.